Treatment with BKI-1748 after

• Tác giả: Samuel L M Arnold, Ryan Choi, Filippo Maria Dini, Ignacio Ferre, Andrew Hemphill, Ana Huertas-López, Matthew A Hulverson, Andrea Largo-de la Torre, Javier Moreno-Gonzalo, Kayode K Ojo, Luis Miguel Ortega-Mora, Michela Re, Roberto Sánchez-Sánchez, Wesley C Van Voorhis
• Ngôn ngữ: eng
• Ký hiệu phân loại: 324.9 Historical and geographic treatment of elections
• Thông tin xuất bản: United States : Antimicrobial agents and chemotherapy , 2025
• Bộ sưu tập: NCBI
• ID: 65223

Tóm tắt

Drug development for congenital toxoplasmosis is challenging since first-line therapy has a high rate of adverse effects and exhibits suboptimal efficacy. Bumped kinase inhibitors (BKIs), targeting protein kinases with small gatekeeper residues, have been found to be effective against